跳至主要内容
临床试验/NCT02327234
NCT02327234已完成不适用

Assessment of Repeated Allergen Challenge and the Effects of Ibuprofen on the Inflammatory Process

University of Saskatchewan1 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2014年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
13
试验地点
1
主要终点
Airway response to inhaled allergen

研究概览

简要总结

The study will assess airway responses in mild atopic asthmatics undergoing repeat allergen challenge testing and will investigate whether ibuprofen changes the response.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis of mild asthma, currently well controlled requiring only a bronchodilator (e.g. salbutamol) as needed and infrequently
  • has allergies that trigger asthma
  • responds to methacholine challenge at 16mg/ml or less
  • has FEV1 > 69.5% predicted

排除标准

  • respiratory illness within 4 weeks
  • other medical condition assessed by the principal investigator that would put the participant at risk or influence the integrity of the data
  • pregnant or lactating females
  • hypersensitivity to ibuprofen

研究组 & 干预措施

Ibuprofen

Experimental

400mg (2X200mg) ibuprofen single dose once

干预措施: ibuprofen (Drug)

Placebo

Placebo Comparator

identical appearing lactose capsules single dose 2 capsules once

干预措施: Placebo (Drug)

结局指标

主要结局

Airway response to inhaled allergen

时间窗: at time of allergen inhalation challenge and for 7 hours after

area under forced expiratory volume in one second versus time curve; 0-3hours (early response) and 3-7 hours (late response)

次要结局

  • Airway response to inhaled methacholine(day before allergen inhalation challenge and 8 hours after allergen inhalation challenge)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Don Cockcroft

Professor

University of Saskatchewan

研究点 (1)

Loading locations...

相似试验